2,366
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Antianxiety activity of Gelsemium sempervirens

, &
Pages 1091-1096 | Received 14 Mar 2009, Accepted 15 Nov 2009, Published online: 22 Sep 2010
 

Abstract

Context: The clinical applications of well-known benzodiazepines as anxiolytic agents are limited because of their side effects. Therefore, the development of new pharmacological agents, from medicinal plants, is well justified.

Objective: Among medicinal plants, Gelsemium sempervirens (L.) Aiton. (Loganiaceae) has been recommended for relief of anxiety in traditional folk medicines. Nevertheless, no pharmacological studies have so far evaluated it in this regard. The purpose of the present study was to investigate the anxiolytic effects of various extracts of the roots and rhizomes of G. sempervirens.

Materials and methods: Petroleum ether, chloroform, methanol, and water extracts of G. sempervirens were prepared by successive extractions using a Soxhlet apparatus, and subsequently evaluated for antianxiety activity using the elevated plus maze model. Diazepam was used as standard drug.

Results: Among various extracts, the methanol extract of G. sempervirens exhibited significant increases in open arm entries and mean time spent in open arms at the dosage of 150 mg/kg. A fraction (F9.4) derived from the methanol extract was also observed to exhibit significant anxiolytic activity at the dose level of 10 mg/kg in the elevated plus maze test.

Conclusion: The present study clearly demonstrated that the methanol extract exerts an anxiolytic effect on mice, and it could serve as a new approach for the treatment of anxiety.

Acknowledgement

The authors are grateful to S. Bhupinder Singh Jauhar, Chairman, Guru Nanak Khalsa Group of Educational Institutions, Yamunanagar, Haryana, India for providing the necessary facilities to carry out this research work.

Declaration of interest

The authors report no declaration of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.